Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

CRYP CHECK IN-VITRO COAGULATION CONTROL SYSTEM

K-Number: K922887 · 1993-02-25

ApplicantPrecision Biologicals, Inc.
Decision Date1993-02-25
Product CodeGGN
Advisory CommitteeHE
DecisionSubstantially Equivalent

Device Summary

CRYP CHECK IN-VITRO COAGULATION CONTROL SYSTEM is the device name listed in this FDA 510(k) record. The listed applicant is Precision Biologicals, Inc.. It received FDA 510(k) clearance on 1993-02-25 under 510(k) number K922887. The device is classified under product code GGN. It was reviewed by the HE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the CRYP CHECK IN-VITRO COAGULATION CONTROL SYSTEM?

CRYP CHECK IN-VITRO COAGULATION CONTROL SYSTEM is a medical device that received FDA 510(k) clearance on 1993-02-25. The listed applicant is Precision Biologicals, Inc.. The 510(k) number is K922887.

When did CRYP CHECK IN-VITRO COAGULATION CONTROL SYSTEM receive FDA 510(k) clearance?

CRYP CHECK IN-VITRO COAGULATION CONTROL SYSTEM received FDA 510(k) clearance on 1993-02-25, under 510(k) number K922887.

Who is the listed applicant for CRYP CHECK IN-VITRO COAGULATION CONTROL SYSTEM?

The FDA 510(k) record lists Precision Biologicals, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for CRYP CHECK IN-VITRO COAGULATION CONTROL SYSTEM?

The FDA product code for CRYP CHECK IN-VITRO COAGULATION CONTROL SYSTEM is GGN.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Precision Biologicals, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K981174CRYO CHECK FACTOR XII DEFICIENT PLASMA MODEL FDP12-10 (1.0ML) AND FDP12-15 (1.5ML)K981173CRYO CHECK FACTOR XI DEFICIENT PLASMA, MODEL FDP11-10 (1.OML) AND FDP11-15 (1.5ML)K982062CRYO-CHECK PNP PLATELET LYSATE, MODEL PNP-10K971219CRYO CHECK INR VALIDATION SETK971222CRYO CHECK APC RESISTANT PLASMAK971223CRYO CHECK FACTOR V DEFICIENT PLASMA

View all 20 devices →

Related Devices (Code: GGN)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K170864VALIDATE D-Dimer Calibration Verification / Linearity Test KitMaine Standards Company, LLCK163498VALIDATE Heparin Calibration Verification/Linearity Test KitMaine Standards Company, LLCK161316George King Coumadin PlasmaGeorge King Bio-Medical, Inc.K162705VALIDATE® D-Dimer Calibration Verification/ Linearity Test KitMaine Standards Company, LLCK152961VALIDATE D-Dimer Calibration Verification/Linearity Test KitMaine Standards Company, LLCK150144VisuCon-F Low Fibrinogen Control PlasmaAffinity Biologicals, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑